(Q24246592)

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Treating behavioural and psychological signs in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Optimal management of behavioural disorders associated with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Agitated behaviors in the elderly. I. A conceptual review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

A description of agitation in a nursing home

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Predictors of aggressive behaviors: a longitudinal study in senior day care centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

The impact of OBRA on medical practice within nursing facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Coma in a patient with Alzheimer's disease taking low dose trazodone and gingko biloba

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Effect of Citalopram, a Selective 5-HT Reuptake Blocker, in Emotionally Disturbed Patients with Dementiaa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

A naturalistic study of trazodone in the treatment of behavioral complications of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

m-Chlorophenylpiperazine as a probe of serotonin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Valproate preparations for agitation in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Psychiatric symptoms in patients with dementia predict the later development of behavioural abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Effects of trazodone on aggressive behavior in seven patients with organic mental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Effects of Buspirone on Agitation Associated With Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Treatment of the agitation of late-life psychosis and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

A metaanalysis of controlled trials of neuroleptic treatment in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

The screen for caregiver burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

'The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia'--1997, 12, 519-527

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021

Serotoninergic treatment of screaming and banging in dementia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021

Tryptophan-trazodone treatment of aggressive behaviour

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021

Trazodone/tryptophan for aggressive behaviour

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021

Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021

Therapeutic trials in Alzheimerʼs disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021

Psychotherapeutic Profile of a New Psychoactive Drug Trazodone (AF-1161)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021

Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004990

7 January 2021